Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder
Published in November 17th, 2008
WOODCLIFF LAKE, N.J., November 14, 2008/PRNewswire/ --Eisai Corporation of North America announced today that the U.S. Food and Drug Administration (FDA) approved Banzel (rufinamide) for the adjunctive treatment of seizures associated with...
Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
No user responded in " FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder "
Subscribes to this post comment rss or trackback url